Absorption and effectiveness of orally administered low molecular weight collagen hydrolysate in rats

Journal of Agricultural and Food Chemistry

Volumn 58, Issue 2, 2010, Pages 835-841

  Mari, Watanabe Kamiyama ^a   Muneshige, Shimizu ^a,b   Shin, Kamiyama ^a,c   Yasuki, Taguchi ^b   Hideyuki, Sone ^c   Fumiki, Morimatsu ^b   Hitoshi, Shirakawa ^a   Yuji, Furukawa ^a   Michio, Komai ^a  

^a TOHOKU UNIVERSITY   (Japan)

^b NIPPON MEAT PACKERS INC   (Japan)

^c UNIVERSITY OF NIIGATA PREFECTURE   (Japan)

Author keywords

Absorption; collagen tripeptide; low molecular weight collagen hydrolysate; osteoporosis; OVX; SHRSP

Indexed keywords

COLLAGEN; PROTEIN HYDROLYSATE;

ABSORPTION; ANIMAL; ARTICLE; BLOOD; CHEMISTRY; CHICKEN; DISEASE MODEL; FEMALE; FEMUR; HUMAN; METABOLISM; MOLECULAR WEIGHT; ORAL DRUG ADMINISTRATION; OSTEOPOROSIS; OVARIECTOMY; RANDOMIZATION; RAT; WISTAR RAT;

ABSORPTION; ADMINISTRATION, ORAL; ANIMALS; CHICKENS; COLLAGEN; DISEASE MODELS, ANIMAL; FEMALE; FEMUR; HUMANS; MOLECULAR WEIGHT; OSTEOPOROSIS; OVARIECTOMY; PROTEIN HYDROLYSATES; RANDOM ALLOCATION; RATS; RATS, WISTAR;

RATTUS; RATTUS NORVEGICUS;

EID: 74849132803     PISSN: 00218561     EISSN: None     Source Type: Journal    
DOI: 10.1021/jf9031487     Document Type: Article

References (35)

1. Nagler-Anderson, C.; Bober, L. A.; Robinson, M. E.; Siskind, G. W.; Thorbecke, G. J. Suppression of type II collagen-induced arthritis by intragastric administration of soluble type II collagen. Proc. Natl. Acad. Sci. U.S.A. 1986, 83, 7443-7446.
2. Trentham, D. E.; Dynesius-Trentham, R. A.; Orav, E. J.; Combitchi, D.; Lorenzo, C.; Sewell, K. L.; Hafler,D. A.; Weiner, H. L. Effects of oral administration of type II collagen on rheumatoid arthritis. Science 1993, 261, 1727-1730.
3. Deal, C. L.; Moskowitz, R. W. Nutraceuticals as therapeutic agents in osteoarthritis. The role of glucosamine, chondroitin sulfate, and collagen hydrolysate. Rheum. Dis. Clin. North Am. 1999, 25, 379-395.
4. Moskowitz, R. W. Role of collagen hydrolysate in bone and joint disease. Semin. Arthritis Rheum. 2000, 30, 87-99.
5. Bello, A. E.; Oesser, S. Collagen hydrolysate for the treatment of osteoarthritis and other joint disorders: a review of the literature. Curr. Med. Res. Opin. 2006, 22, 2221-2232.
6. Clark, K. L.; Sebastianelli, W.; Flechsenhar, K. R.; Aukermann, D. F.; Meza, F.; Millard, R. L.; Deitch, J. R.; Sherbondy, P. S.; Albert, A. 24-Week study on the use of collagen hydrolysate as a dietary supplement in athletes with activity-related joint pain. Curr. Med. Res. Opin. 2008, 24, 1485-1496.
7. Andrianarivo, A. G.; Robinson, J. A.; Mann, K. G.; Tracy, R. P. Growth on type I collagen promotes expression of the osteoblastic phenotype in human osteosarcoma MG-63 cells. J. Cell. Physiol. 1992, 153, 256-265.
8. Lynch, M. P.; Stein, J. L.; Stein, G. S.; Lian, J. B. The influence of type I collagen on the development and maintenance of the osteoblast phenotype in primary and passaged rat calvarial osteoblasts: modification of expression of genes supporting cell growth, adhesion, and extracellular matrix mineralization. Exp. Cell Res. 1995, 216, 35-45.
9. Postlethwaite, A. E.; Kang, A. H. Collagen-and collagen peptideinduced chemotaxis of human blood monocytes. J. Exp. Med. 1976, 143, 1299-1307.
10. Postlethwaite, A. E.; Seyer, J. M.; Kang, A. H. Chemotactic attraction of human fibroblasts to type I, II, and III collagens and collagen-derived peptides. Proc. Natl. Acad. Sci. U.S.A. 1978, 75, 871-875.
11. (11) Laskin, D. L.; Kimura, T.; Sakakibara, S.; Riley, D. J.; Berg, R. A. Chemotactic activity of collagen-like polypeptides for human peripheral blood neutrophils. J. Leukocyte Biol. 1986, 39, 255-266. (Pubitemid 16175034)
12. Oshima, G.; Shimabukuro, H.; Nagasawa, K. Peptide inhibitors of angiotensin I-converting enzyme in digests of gelatin by bacterial collagenase. Biochim. Biophys. Acta 1979, 566, 128-137.
13. Kim, S. K.; Byun, H. G.; Park, P. J.; Shahidi, F. Angiotensin I converting enzyme inhibitory peptides purified from bovine skin gelatin hydrolysate. J. Agric. Food Chem. 2001, 49, 2992-2997.
14. Saiga, A.; Iwai, K.; Hayakawa, T.; Takahata, Y.; Kitamura, S.; Nishimura, T.; Morimatsu, F. Angiotensin I-converting enzymeinhibitory peptides obtained from chicken collagen hydrolysate. J. Agric. Food Chem. 2008, 56, 9586-9591.
15. Knight, C. G.; Morton, L. F.; Onley,D. J.; Peachey, A. R.; Ichinohe, T.; Okuma, M.; Farndale, R. W.; Barnes, M. J. Collagen-platelet interaction: Gly-Pro-Hyp is uniquely specific for platelet Gp VI and mediates platelet activation by collagen. Cardiovasc. Res. 1999, 41, 450-457.
16. Adam, M.; Spacek, P.; Hulejov-a, H.; Gali-aov-a, A.; Blahos, J. Postmenopausal osteoporosis. Treatment with calcitonin and a diet rich in collagen proteins. Cas Lek Cesk. 1996, 135, 74-78.
17. Koyama, Y.; Hirota, A.; Mori, H.; Takahara, H.; Kuwaba, K.; Kusubata, M.; Matsubara, Y.; Kasugai, S.; Itoh, M.; Irie, S. Ingestion of gelatin has differential effect on bone mineral density and body weight in protein undernutrition. J. Nutr. Sci. Vitaminol. (Tokyo) 2001, 47, 84-86.
18. Wu, J.; Fujioka, M.; Sugimoto, K.; Mu, G.; Ishimi, Y. Assessment of effectiveness of oral administration of collagen peptide on bone metabolism in growing and mature rats. J. Bone Miner. Metab. 2004, 22, 547-553.
19. Tsuruoka, N.; Yamato, R.; Sakai, Y.; Yoshitake, Y.; Yonekura, H. Promotion by collagen tripeptide of type I collagen gene expression in human osteoblastic cells and fracture healing of rat femur. Biosci. Biotechnol. Biochem. 2007, 71, 2680-2687.
20. Hata, S.; Hayakawa, T.; Okada, H.; Hayashi, K.; Akimoto, Y.; Yamamoto, H. Effect of oral administration of high advancedcollagen tripeptide (HACP) on bone healing process in rat. J. Hard Tissue Biol. 2008, 17, 17-22.
21. Mizuno, M.; Fujisawa, R.; Kuboki, Y. Type I collagen-induced osteoblastic differentiation of bone-marrow cells mediated by collagenalpha2beta1 integrin interaction. J. Cell. Physiol. 2000, 184, 207-213.
22. (22) Mizuno, M.; Kuboki, Y. Osteoblast-related gene expression of bone marrow cells during the osteoblastic differentiation induced by type I collagen. J. Biochem. 2001, 129, 133-138. (Pubitemid 32150490)
23. Suzawa, M.; Tamura, Y.; Fukumoto, S.; Miyazono, K.; Fujita, T.; Kato, S.; Takeuchi, Y. Stimulation of Smad1 transcriptional activity by Ras-extracellular signal-regulated kinase pathway: a possible mechanism for collagen-dependent osteoblastic differentiation. J. Bone Miner. Res. 2002, 17, 240-248.
24. Oesser, S.; Adam, M.; Babel, W.; Seifert, J. Oral administration of (14)C labeled gelatin hydrolysate leads to an accumulation of radioactivity in cartilage of mice (C57/BL). J. Nutr. 1999, 129, 1891-1895.
25. Iwai, K.; Hasegawa, T.; Taguchi, Y.; Morimatsu, F.; Sato, K.; Nakamura, Y.; Higashi, A.; Kido, Y.; Nakabo, Y.; Ohtsuki, K. Identification of food-derived collagen peptides in human blood after oral ingestion of gelatin hydrolysates. J. Agric. Food Chem. 2005, 53, 6531-6536.
26. Shigemura, Y.; Iwai, K.; Morimatsu, F.; Iwamoto, T.; Mori, T.; Oda, C.; Taira, T.; Park, E. Y.; Nakamura, Y.; Sato, K. Effect of Prolyl-hydroxyproline (Pro-Hyp), a food-derived collagen peptide in human blood, on growth of fibroblasts from mouse skin. J. Agric. Food Chem. 2009, 57, 444-449.
27. Fei, Y. J.; Kanai, Y.; Nussberger, S.; Ganapathy, V.; Leibach, F. H.; Romero, M. F.; Singh, S. K.; Boron, W. F.; Hediger, M. A. Expression cloning of a mammalian proton-coupled oligopeptide transporter. Nature 1994, 368, 563-566.
28. Liu, W.; Liang, R.; Ramamoorthy, S.; Fei, Y. J.; Ganapathy, M. E.; Hediger, M. A.; Ganapathy, V.; Leibach, F. H. Molecular cloning of PEPT 2, a new member of the H+/peptide cotransporter family, from human kidney. Biochim. Biophys. Acta 1995, 1235, 461-466.
29. Ganapathy, M. E.; Brandsch, M.; Prasad, P. D.; Ganapathy, V.; Leibach, F. H. Differential recognition of beta -lactam antibiotics by intestinal and renal peptide transporters, PEPT 1 and PEPT 2. J. Biol. Chem. 1995, 270, 25672-25677.
30. Saito, H.; Terada, T.; Okuda, M.; Sasaki, S.; Inui, K. Molecular cloning and tissue distribution of rat peptide transporter PEPT2. Biochim. Biophys. Acta 1996, 1280, 173-177.
31. Aito-Inoue, M.; Lackeyram, D.; Fan, M. Z.; Sato, K.; Mine, Y. Transport of a tripeptide, Gly-Pro-Hyp, across the porcine intestinal brush-border membrane. J. Pept. Sci. 2007, 13, 468-474.
32. Meilman, E.; Urivetzky, M. M.; Rapoport, C. M. Urinary hydroxyproline peptides. J. Clin. Invest. 1963, 42, 40-50.
33. Mizutani, K.; Ikeda, K.; Ishikado, A.; Kawai, Y.; Yamori, Y. Antihypertensive effect of cattle bone collagen-derived peptides in ovariectomized stroke-prone spontaneously hypertensive rats. Clin. Exp. Pharmacol. Physiol. 2000, 27, 416-417.
34. Mizutani, K.; Ikeda, K.; Kawai, Y.; Yamori, Y. Resveratrol attenuates ovariectomy-induced hypertension and bone loss in stroke-prone spontaneously hypertensive rats. J. Nutr. Sci. Vitaminol. (Tokyo) 2000, 46, 78-83.
35. Nomura, Y.; Oohashi, K.; Watanabe, M.; Kasugai, S. Increase in bone mineral density through oral administration of shark gelatin to ovariectomized rats. Nutrition 2005, 21, 1120-1126.